3 Undervalued Personal Care Products Stocks for Thursday, September 17
Discover the top 3 undervalued Personal Care Products stocks for Thursday, September 17 based on AAII’s Stock Grades.Jenna Brashear
Stock Evaluator: Nu Skin Enterprises, Inc. (NUS)
Nu Skin Enterprises, Inc. NUS
$4.64
0.06
1.20%
September 17, 2026 2:44:48 PM
EST
Volume: 176,935
After Hours: $120.37
0.15
|
0.12%
November 10, 2021 7:59 PM
EST
Volume: 72,713
USD
NYSE | DELAYED PRICE
| SECTOR | INDUSTRY |
| Consumer Staples | Personal Care Products |
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Nu Skin Enterprises, Inc., together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa, ageLOC LumiSpa iO, and Nu Skin RenuSpa iO; ageLOC TruFace and ageLOC LumiSpa cleansers and devices; Prysm iO, a data-enabled wellness device; and Nutricentials beauty and Beauty Focus wellness brands. The company also provides wellness products, such as ageLOC TRME, LifePak, and Beauty Focus. In addition, it is the research and product development of skin care products, nutritional supplements, and devices. The company sells its products under the Nu Skin, Pharmanex, and ageLOC brands through retail stores, website, digital platforms, and independent direct sellers and marketers, as well as a service center and independent marketers. It serves Mainland China; South Korea; Southeast Asia/Pacific, which includes Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Australia, New Zealand and other markets; Americas, comprising Canada, Latin America and the United States; Japan; Hong Kong/Taiwan, consists of Macau; and Europe & Africa, which includes markets in Europe as well as South Africa. Nu Skin Enterprises, Inc. was founded in 1984 and is headquartered in Provo, Utah.
Commentary & Analysis
Why Nu Skin Enterprises, Inc.’s (NUS) Stock Is Up 6.02%
As of Wednesday, September 02, Nu Skin Enterprises, Inc.’s NUS share price has surged by 6.02%, which has investors questioning if this is right time to sell.Rosalio Madrigal
Is Nu Skin Enterprises, Inc. (NUS) Overvalued?
We dive into why Nu Skin Enterprises, Inc. (NUS) could be considered overvalued on 2026-08-18, based on AAII’s Value Score and Grade.Michael Rose
Why Nu Skin Enterprises, Inc.’s (NUS) Stock Is Down 6.93%
As of Tuesday, August 11, Nu Skin Enterprises, Inc.’s NUS share price has dipped by 6.93%, which has investors questioning if this is right time to buy.Jenna Brashear
What You Need to Know About Nu Skin Enterprises, Inc.'s Q3 Earnings
Nu Skin Enterprises, Inc.'s fiscal Q3 earnings report was released on Monday, August 10. Let's dive in to see if (NUS) missed or beat analyst's expectations.Jenna Brashear
Financial Summary
| Share Statistics | NUS | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $222.9 | $258.3 | 28% |
|
| Shares Out (Mil) | 48.6 | 32.8 | 47% |
|
| Institutional Ownership | 96.4% | 58.4% | 70% |
|
| Float (Mil) | 47.3 | 41.9 | 46% |
|
| Beta | 0.97 | 0.54 | 58% |
|
| Avg Daily Volume (000s) | 524 | 98 | 60% |
|
| Price Change (52-week) |
(61.3%) | 57.4% | 13% |
|
| Growth | NUS | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | (10.5%) | 0.9% | 5% |
|
| Net Income (5yr) | (3.5%) | (7.5%) | 35% |
|
| EPS (5yr) | (2.6%) | (0.2%) | 28 |
|
| Dividends (5yr) | (30.7%) | 0.0% | 62% |
|
| Cash Flow (5yr) | (3.9%) | (14.9%) | 61% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 1 | 1 | 1 | |
| Current EPS | $0.210 | $0.820 | $1.160 | |
| Month Ago EPS | $0.210 | $0.820 | $1.160 | |
| # Rev Up | 1 | 0 | 0 | |
| # Rev Down | 0 | 1 | 1 | |
| Three Months Ago EPS | $0.320 | $1.000 | $1.320 | |
| Year/Year Chg | (104.1%) | (74.2%) | na | |
| Financials | NUS | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $1,375 | $571 | 55% |
|
| Net Income (TTM) (Mil) | ($216) | ($1) | 6% |
|
| EPS (TTM) | ($4.444) | $0.000 | 9% |
|
| Operating Cash Flow (TTM) (Mil) | $51 | $25 | 46% |
|
| Net Cash Flow (TTM) (Mil) | ($75) | $1 | 16% |
|
| Long-Term Debt (Q1) (Mil) | $250 | $42 | 52% |
|
| Enterprise Value (Q1) (Mil) | $327 | $357 | 30% |
|
| Valuation | NUS | Industry Median |
Percentile (All Stocks) |
|
| P/B | 0.41 | 1.85 | 6% |
|
| P/E | na | 15.5 | na |
|
| Dividend Yield | 5.2% | 0.0% | 94% |
|
| PEG (5yr hist) | na | 0.6 | na |
|
| Ratios | NUS | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 69.2% | 62.9% | 80% |
|
| Net Margin | (15.7%) | 1.2% | 18% |
|
| ROA | (16.9%) | (1.5%) | 21% |
|
| ROE | (32.5%) | 4.8% | 19% |
|
| Liabilities to Assets | 51.6% | 49.5% | 44% |
|
| F-Score | 4 | 4 | 33% |
|
Nu Skin Enterprises, Inc. did not pass any screens on 9/16/2026.
